FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to neurology, and can be used to treat chronic traumatic encephalopathy (CTE). Present method and use of the invention includes administering to the subject an effective amount of a compound of formula (I).
EFFECT: use of inventions allows to prevent the development of CTE due to inhibition of phosphorylation of microtubule-associated protein tau.
12 cl, 5 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING NEUROLOGICAL DISORDERS | 2008 |
|
RU2492137C2 |
LEUCINE, ACETYLLECINE AND RELATED ANALOGUES FOR TREATMENT OF DISEASE | 2020 |
|
RU2815373C2 |
CHROMON OXIME NEW DERIVATIVE AND ITS USE AS ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS | 2015 |
|
RU2672569C2 |
ANTIBODIES SPECIFIC TO HYPERPHOSPHORYLATED TAU-PROTEIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2760875C1 |
NOVEL N-SULPHANILAMIDE DERIVATIVE OF PYRIMIDIN-4(1H)-ONE, HAVING CEREBROPROTECTIVE ACTIVITY FOR TREATING CHRONIC TRAUMATIC ENCEPHALOPATHY | 2019 |
|
RU2711613C1 |
CITRIC SALT OF INDOLE DERIVATIVE, METHOD FOR PRODUCING THEREOF, ADMINISTERING THEREOF AND BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2415137C2 |
ANTIBODIES, SPECIFIC TO HYPERPHOSPHORYLATED TAU-PROTEIN, AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2727911C2 |
METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM | 2017 |
|
RU2763493C2 |
CYSTEAMINE DIOXYGENASE-RESISTANT ANALOGUES OF CYSTEAMINE AND THEIR USE | 2016 |
|
RU2766579C2 |
NEW FUNCTIONALIZED 1,3-BENZENEDIOLS AND METHOD FOR APPLICATION THEREOF FOR TREATMENT OF HEPATIC ENCEPHALOPATHY | 2015 |
|
RU2676475C2 |
Authors
Dates
2018-12-12—Published
2014-07-02—Filed